Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Moran

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Diabetes Care|June 1, 2014
Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetesCarol Forsblom, John Moran, Valma Harjutsalo, et al.
Diabetes Care|February 11, 2011
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetesMerlin C Thomas, John Moran, Carol Forsblom, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2008
Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritinToros Kapoian, Neeta B O'Mara, Ajay K Singh, et al.
Nephron. Clinical Practice|November 18, 2014
Circulating endotoxaemia and frequent haemodialysis schedulesHelen J Jefferies, Lisa E Crowley, Laura E A Harrison, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 2, 2025
ENaC contributes to macrophage dysfunction in cystic fibrosisJohn Moran, Courtney Pugh, Nevian Brown, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
ENaC contributes to macrophage dysfunction in cystic fibrosisJohn Moran, Courtney Pugh, Nevian Brown, et al.
Annals of Surgical Oncology|May 27, 2021
Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and SurgeonsNima Ahmadi, Danko Kostadinov, Shinichiro Sakata, et al.
Diseases of the Colon and Rectum|June 10, 2025
International Prospective Quality of Life in Patients With Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United Kingdom and AustraliaDaniel Steffens, Suzanne Alves, Cherry E Koh, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 25, 2010
Dialysis practices that distinguish top- versus bottom-performing facilities by hemoglobin outcomesBrennan M R Spiegel, Roger Bolus, Amar A Desai, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 21, 2017
Patient characteristics in variable left ventricular recovery from Takotsubo syndromeJae I Kim, Charan Yerasi, Alaa Azzouqa, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Diabetes Care|June 1, 2014
Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetesCarol Forsblom, John Moran, Valma Harjutsalo, et al.
Diabetes Care|February 11, 2011
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetesMerlin C Thomas, John Moran, Carol Forsblom, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2008
Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritinToros Kapoian, Neeta B O'Mara, Ajay K Singh, et al.
Nephron. Clinical Practice|November 18, 2014
Circulating endotoxaemia and frequent haemodialysis schedulesHelen J Jefferies, Lisa E Crowley, Laura E A Harrison, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 2, 2025
ENaC contributes to macrophage dysfunction in cystic fibrosisJohn Moran, Courtney Pugh, Nevian Brown, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
ENaC contributes to macrophage dysfunction in cystic fibrosisJohn Moran, Courtney Pugh, Nevian Brown, et al.
Annals of Surgical Oncology|May 27, 2021
Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and SurgeonsNima Ahmadi, Danko Kostadinov, Shinichiro Sakata, et al.
Diseases of the Colon and Rectum|June 10, 2025
International Prospective Quality of Life in Patients With Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United Kingdom and AustraliaDaniel Steffens, Suzanne Alves, Cherry E Koh, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 25, 2010
Dialysis practices that distinguish top- versus bottom-performing facilities by hemoglobin outcomesBrennan M R Spiegel, Roger Bolus, Amar A Desai, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 21, 2017
Patient characteristics in variable left ventricular recovery from Takotsubo syndromeJae I Kim, Charan Yerasi, Alaa Azzouqa, et al.
Pageof 10